A Proof of Concept Study to Evaluate Exosomes From Human Mesenchymal Stem Cells in Women With Premature Ovarian Insufficiency (POI)

Summary

The VL-POI-01 study is designed to evaluate the safety and efficacy of human placental mesenchymal stem cell derived exosome treatment in patients with premature ovarian insufficiency (POI) and diminished ovarian reserve.

Timeline

Start

2023-10-06

Primary completion

2025-10

Completion

2025-12

Outcome

Outcome not reported

Stopped: “Sponsor request”

Drugs

Indications